Key result
Combined CMR and 18F-FDG PET yields near-perfect accuracy for detecting malignant cardiac masses with ~0.97 AUC.
Why the study?
The diagnostic evaluation of cardiac masses remains challenging, and a direct comparison of combined imaging strategies including CMR, CCT, and 18F-FDG PET had never been provided.
Does an integrated multimodality imaging approach (combining CMR, CCT, and 18F-FDG PET) improve diagnostic accuracy for detecting malignancy in patients with suspected cardiac masses compared to individual imaging modalities?
Observational (n=142)
Does an integrated multimodality imaging approach (combining CMR, CCT, and 18F-FDG PET) improve diagnostic accuracy for detecting malignancy in patients with suspected cardiac masses compared to individual imaging modalities?
In patients with suspected cardiac masses, CMR is the most accurate single imaging modality, while combining CMR with 18F-FDG PET achieves the highest diagnostic accuracy for malignancy detection (AUC 0.97, NPV 100%), and CCT plus 18F-FDG PET provides a reliable alternative when CMR is unfeasible.
Supports CMR ± 18F-FDG PET for suspected cardiac masses; leaves open prospective validation before practice change.
Background The diagnostic evaluation of cardiac masses (CMs) remains challenging. A multimodality imaging approach is essential for accurate CMs characterization. However, a direct comparison of combined imaging strategies, including cardiac magnetic resonance (CMR), cardiac computed tomography (CCT), and 18F-Fluorodeoxyglucose positron emission tomography (18F-FDG PET), has never been provided for CMs. Objectives To compare the diagnostic accuracy of multiparametric scores at CMR, CCT, and 18F-FDG PET, individually and in combination, in determining the presence and the malignant nature of suspected CMs compared to histology. Methods This prospective study included patients with suspected CMs who underwent echocardiography, CCT, CMR, and 18F-FDG PET within two months from first medical contact. Definite diagnosis was confirmed by histology or radiological resolution after anticoagulation for thrombi. Diagnostic performance was assessed using receiver operating characteristic (ROC) curves and compared with the DeLong test. A Bonferroni correction was applied to account for multiple comparisons. Classification Tree Analysis evaluated the incremental diagnostic value of PET after CMR or CCT. Results Among 142 patients, 77 (54%) had malignant CMs. Echocardiography had the lowest diagnostic accuracy (Area Under the Curve, AUC, 0.77 [95% Confidence Interval, CI,: 0.71–0.84]), missing the detection of 12.6% of CMs. CMR was the most accurate modality (AUC 0.94 [95% CI: 0.90–0.98]), significantly outperforming CCT (AUC 0.85 [95% CI: 0.80–0.91], Bonferroni-adjusted p=0.024) and 18F-FDG PET (AUC 0.85 [95% CI: 0.79–0.91], Bonferroni-adjusted p=0.048). The combination of CMR and 18F-FDG PET achieved the highest diagnostic accuracy (AUC 0.97 [95% CI: 0.94–1.00]; Positive Predictive Value, PPV, 95.1%; Negative Predictive Value, NPV, 100%). CCT combined with 18F-FDG PET also showed incremental diagnostic accuracy (AUC 0.92 [95% CI: 0.87–0.97]; PPV 91.2%; NPV 93.5%). Classification Tree Analysis confirmed that the integration of 18F-FDG PET with CMR or CCT increased malignancy detection (97.2% and 92.3% correctly classified, respectively). Similarly, integrating CMR and CCT significantly improved accuracy (AUC 0.95 [95% CI: 0.91–0.99]; PPV 93.8%; NPV 96.8%) compared to CCT alone (Bonferroni- adjusted p=0.006). Conclusion Although CMR is the most accurate imaging modality, its combination with 18F-FDG PET in inconclusive cases offers the best diagnostic performance for malignancy detection. When CMR is not feasible, combining CCT with PET offers a reliable alternative.
No takes yet. Share an insight, caveat, or question.
Moretti et al. (2026) conducted an observational in Suspected cardiac masses (n=142). Combined CMR and 18F-FDG PET vs. Individual and combined imaging modalities (Echocardiography, CCT, CMR, 18F-FDG PET) compared to histology or radiological resolution was evaluated on Diagnostic accuracy in determining the presence and malignant nature of suspected cardiac masses (AUC 0.97, 95% CI 0.94-1.00). Combining CMR and 18F-FDG PET achieved the highest diagnostic accuracy for detecting malignant cardiac masses (AUC 0.97; 95% CI 0.94-1.00; PPV 95.1%; NPV 100%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: